Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments
Magdalena Misiak-Gałązka, Joanna Zozula, Lidia Rudnicka
American Journal of Clinical Dermatology (2020) Vol. 21, Iss. 3, pp. 355-370
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Challenges and Future Trends in the Treatment of Psoriasis
Hyun Ji Lee, Miri Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13313-13313
Open Access | Times Cited: 108
Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease
Helena Iznardo, L. Puig
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4344-4344
Open Access | Times Cited: 60
Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options
Alan Menter, Abby S. Van Voorhees, Sylvia Hsu
Dermatology and Therapy (2021) Vol. 11, Iss. 6, pp. 1917-1929
Open Access | Times Cited: 57
Therapeutic potential of targeting interleukin‐1 family cytokines in chronic inflammatory skin diseases*
Laura Calabrese, Zeno Fiocco, Takashi Satoh, et al.
British Journal of Dermatology (2022) Vol. 186, Iss. 6, pp. 925-941
Open Access | Times Cited: 44
Targeting IL-36 in Inflammatory Skin Diseases
Ryo Fukaura, Masashi Akiyama
BioDrugs (2023) Vol. 37, Iss. 3, pp. 279-293
Closed Access | Times Cited: 30
Case Report: Successful management of refractory palmoplantar pustulosis with upadacitinib
Boyun Yang, Hanxiao Yu, Wo Yao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Pustular Psoriasis: From Pathophysiology to Treatment
Giovanni Genovese, Chiara Moltrasio, Nicoletta Cassano, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1746-1746
Open Access | Times Cited: 52
Drugs and the skin: A concise review of cutaneous adverse drug reactions
Blanca R. Del Pozzo‐Magaña, Carmen Liy‐Wong
British Journal of Clinical Pharmacology (2022) Vol. 90, Iss. 8, pp. 1838-1855
Open Access | Times Cited: 33
Deficiency of interleukin‐36 receptor antagonist (DITRA): An analysis of 58 Chinese patients in a tertiary hospital in Taiwan
Chang‐Yu Hsieh, Yi‐Wei Huang, Yi‐Hsuan Huang, et al.
Experimental Dermatology (2023) Vol. 32, Iss. 8, pp. 1272-1278
Closed Access | Times Cited: 17
Efficacy of dupilumab in palmoplantar pustulosis treatment highlights the role of Th2 inflammation
Yuxin Zheng, Xi‐Bei Chen, Zhaoyuan Wang, et al.
Allergy (2024) Vol. 79, Iss. 5, pp. 1361-1364
Closed Access | Times Cited: 8
Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report
Pengfei Wen, Chuan Liu, Tingting Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
<p>Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations</p>
Egídio Freitas, Maria Alexandra Rodrigues, Tiago Torres
Clinical Cosmetic and Investigational Dermatology (2020) Vol. Volume 13, pp. 561-578
Open Access | Times Cited: 45
Recent advances in palmoplantar pustulosis
Alexandra Maria Giovanna Brunasso, Cesare Massone
Faculty Reviews (2021) Vol. 10
Open Access | Times Cited: 35
Interleukins and Psoriasis
Qi Zhu, Linna Zhao, Haining Ding, et al.
Journal of Cutaneous Medicine and Surgery (2024) Vol. 28, Iss. 2, pp. NP19-NP35
Closed Access | Times Cited: 6
Pustular psoriasis as an autoinflammatory keratinization disease (AiKD): Genetic predisposing factors and promising therapeutic targets
Masashi Akiyama
Journal of Dermatological Science (2021) Vol. 105, Iss. 1, pp. 11-17
Open Access | Times Cited: 31
Low-Density Granulocytes in Immune-Mediated Inflammatory Diseases
Xin Ning, Wenming Wang, Hongzhong Jin
Journal of Immunology Research (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 22
Line‐field confocal optical coherence tomography: a new tool for non‐invasive differential diagnosis of pustular skin disorders
Linda Tognetti, Élisa Cinotti, Francesca Falcinelli, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 10, pp. 1873-1883
Open Access | Times Cited: 21
A Review of the Clinical Trial Landscape in Psoriasis: An Update for Clinicians
Anastasia Drakos, Ronald Vender
Dermatology and Therapy (2022) Vol. 12, Iss. 12, pp. 2715-2730
Open Access | Times Cited: 19
Characteristics and Burdens of Disease in Patients from Beijing with Generalized Pustular Psoriasis and Palmoplantar Pustulosis: Multicenter Retrospective Cohort Study Using a Regional Database
Hai-Meng Wang, Jiaming Xu, Hongzhong Jin
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 6, pp. 991-1002
Closed Access | Times Cited: 11
The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab
Jason E. Hawkes, Sudha Visvanathan, James G. Krueger
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Exploring the effect of deucravacitinib in patients with palmoplantar pustular psoriasis
David A. De Luca, Cristian Papara, Tomasz Hawro, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 4
A brief guide to pustular psoriasis for primary care providers
Jeffrey Crowley, David M. Pariser, Paul S. Yamauchi
Postgraduate Medicine (2020) Vol. 133, Iss. 3, pp. 330-344
Open Access | Times Cited: 29
Cigarette Smoke Underlies the Pathogenesis of Palmoplantar Pustulosis via an IL-17A–Induced Production of IL-36γ in Tonsillar Epithelial Cells
Keiju Kobayashi, Ryuta Kamekura, Junji Kato, et al.
Journal of Investigative Dermatology (2020) Vol. 141, Iss. 6, pp. 1533-1541.e4
Open Access | Times Cited: 29
Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study
Yukari Okubo, Hitomi Morishima, Richuan Zheng, et al.
The Journal of Dermatology (2021) Vol. 48, Iss. 12, pp. 1838-1853
Open Access | Times Cited: 24
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study
Tadashi Terui, Yukari Okubo, Satomi Kobayashi, et al.
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 5, pp. 837-847
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top